
1. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2020 Mar 25;32(2):174-180. doi:
10.16250/j.32.1374.2019277.

[Analysis of chloroquine-resistant gene polymorphisms in Plasmodium falciparum
imported into China in 2012 and 2018].

[Article in Chinese; Abstract available in Chinese from the publisher]

Yan H(1), Wang XX(1), Feng J(1), Zhang L(1), Yin JH(1), Li M(1), Xia ZG(1), Huang
F(1).

Author information: 
(1)National Institute of Parasitic Diseases, Chinese Center for Disease Control
and Prevention; Chinese Center for Tropical Diseases Research; WHO Collaborating 
Centre for Tropical Diseases; National Center for International Research on
Tropical Diseases, Ministry of Science and Technology; Key Laboratory of Parasite
and Vector Biology, National Health Commission, Shanghai 200025, China.

OBJECTIVE: To detect the chloroquine-resistant molecular marker polymorphisms in 
Plasmodium falciparum imported into China, investigate the mutation types of P.
falciparum chloroquine resistant transporter (Pfcrt) gene at positions 72 to 76, 
and analyze the specificity of the P. falciparum specimens with different
origins.
METHODS: A total of 674 filter paper blood samples were collected from the
National Malaria Diagnosis Reference Laboratory of China in 2012 and 2018. The
amino acid po- sitions 72 to 76 of the Pfcrt gene on chromosome 7 were amplified 
using nested PCR assay and sequenced, and the sequencing results of the target
gene fragment and the geographical region-specific prevalence of the mutations in
the Pfcrt gene were analyzed.
RESULTS: Among the 674 imported P. falciparum malaria cases in China in 2012 and 
2018, 99.5% (644/674) were from Africa, which were predominantly from western and
central Africa (80.4%, 518/644), and 4.5% (30/674) from Southeast Asia and
Oceania (Papua New Guinea). A total of 4 site mutations (C72S, M74I, N75E and
K76T) and 5 haplotypes (CVMNK, CVIET and SVMNT and two mixed types) were
identified, with haplotypes CVMNK and CVIET present in parasites of both African 
and Southeast Asian origins, SVMNT detected in Southeast Asia (Myanmar) and Papua
New Guinea isolates, the mixed type of haplo- types CVMNK/CVIET detected in P.
falciparum of African and Southeast Asian origins, and the mixed type of
haplotypes CVMNK/SVMNT detected only in the Myanmar isolate. Most P. falciparum
parasites of the African origin carried the wild-type Pfcrt allele (77.7%,
478/615), and 68.0% (17/25) of the P. falciparum parasites of the Southeast Asian
and Papua New Guinea or- igins harbored chloroquine resistant molecular markers
(χ2 = 28.5, P < 0.05). The constituent ratio of the wild- and mutant-type Pfcrt
allele varied in different geographical regions of Africa (P < 0.01), and the
lowest prevalence of the wild-type Pfcrt allele was seen in western Africa.
CONCLUSIONS: Among the 674 imported malaria cases in China in 2012 and 2018, the 
P. falciparum imported from Sotheast Asia habors a higher proportion of
resistance to chloroquine and a higher molecular polymophism at ami- no acid
positions 72 to 76 of the Pfcrt gene than the parasite of the African origin.

Publisher: ［摘要］ 目的 对 2012 年和 2018 年我国输入性恶性疟原虫样本氯喹抗性分子标记位点基因多态性进行检测, 分析恶性
疟原虫氯喹抗性转运蛋白基因 (Plasmodium falciparum chloroquine resistant transporter, Pfcrt) 第 
72～76 位密码子抗性相关 位点突变类型, 并分析不同输入来源样本的特异性。方法 收集 2012 年和 2018 年国家疟疾诊断参比实验室 674 例输入
性恶性疟病例滤纸血样本, 以样本中恶性疟原虫7号染色体上 Pfcrt 基因第 72～76 位点为扩增片段, 采用巢式 PCR 法进 行扩增并测序,
对目的产物片段测序结果、地理分布等特征进行统计分析。结果 2012 年和 2018 年我国 674 例输入性 恶性疟病例中, 95.5% (644/674 )
来自非洲, 其余 4.5% (30/674) 来自东南亚和大洋洲 (巴布亚新几内亚); 非洲又以西非和 中非为主 (占非洲样本的 80.4%,
518/644)。共检测到 C72S、M74I、N75E、K76T 4 个位点突变和 5 种单体型类型 (CVMNK、CVIET、SVMNT 和两种混合型),
其中 CVMNK 与 CVIET 为非洲和东南亚地区恶性疟原虫共有的单体型类型, SVMNT 仅在 东南亚 (缅甸) 和巴布亚新几内亚输入样本中检测出; 2
种混合型为 CVMNK/CVIET 和 CVMNK/SVMNT, 前者在非洲和东 南亚输入样本中分布,
后者仅在东南亚缅甸来源样本中检出。自非洲输入的样本野生型较多, 占 77.7% (478/615); 而自 东南亚和巴布亚新几内亚输入的样本中,
抗性分子标记样本占 68.0% (17/25), 两者差异有统计学意义 (χ2 = 28.5, P < 0.05)。非洲不同地区来源样本中,
抗性基因比例和野生型构成差异有统计学意义 (P < 0.01), 西非野生型所占比例最 低。结论 2012 年和 2018 年我国 674
例输入性恶性疟病例样本中, 自东南亚输入的恶性疟原虫 Pfcrt 基因第 72～76 位点 抗性基因比例和分子多态性均较非洲来源样本高。.
DOI: 10.16250/j.32.1374.2019277 
PMID: 32458607  [Indexed for MEDLINE]

